(S)-CR8 ≥97% (by HPLC)
270-509-M005
89148-132EA
296.03
USD
89148-132
(S)-CR8 ≥97% (by HPLC)
(S)-CR8
Inhibitor of CDK and GSK
Potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases (CDKs) 1, 2, 5, 7 and 9. Two to four-fold more potent inhibitor of CDKs than (R)-roscovitine (Prod. No. BML-CC205). Induces apoptotic cell death more potently than (R)-roscovitine. Equally potent inhibitor of CDKs as (R)-CR8 (Prod. No. ALX-270-508). Less potent glycogen synthase kinase (GSK-3alpha/beta) inhibitor than (R)-CR8.
Synthetic.
Formula:
C₂₄H₂₉N₇O |
CAS Number:
1084893-56-0 |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...